About

Transforming Detection. Improving Lives.^TM

Creating a world where oral cancer doesn’t stand a fighting chance.^TM

Vigilant Biosciences^Ⓡ is leading the charge in developing cutting-edge solutions that accelerate oral cancer detection. Our point-of-care solution is simple, accurate*, and cost-effective. We empower clinicians working to improve patient outcomes through earlier intervention.

The innovative BeVigilant^TM OraFusion System employs patented technology that detects specific protein markers clinically shown to be associated with early-stage oral cancers. Learn more about our technology:

Discover

Standing together to transform the early detection of oral cancer.

Our Mission

To save lives by providing world-class early-detection solutions for cancer.

Our first early cancer detection product:

The BeVigilant^TM OraFusion System aids clinicians with identifying patients at risk for oral cancer.

Leadership

With deep-seated clinical expertise and decades of leadership experience in healthcare diagnostics and the oncology space, the Vigilant Biosciences® leadership team is committed to transforming early oral cancer detection and improving patient outcomes.